| Year | Firm | Client | Amount | Doc |
|---|---|---|---|---|
| 2026 3rd Quarter - Report |
GENENTECH, INC | GENENTECH INC | $2,890,000 | |
| 2026 2nd Quarter - Report |
GENENTECH, INC | GENENTECH INC | $1,810,000 | |
| 2026 AMENDED |
GENENTECH, INC | GENENTECH INC | $3,780,000 | |
| 2026 1st Quarter - Report |
GENENTECH, INC | GENENTECH INC | $378,000 | |
| 2025 4th Quarter - Report |
GENENTECH, INC | GENENTECH INC | $1,850,000 | |
| 2025 3rd Quarter - Report |
GENENTECH, INC | GENENTECH INC | $3,480,000 | |
| 2025 2nd Quarter - Report |
GENENTECH, INC | GENENTECH INC | $1,940,000 | |
| 2025 1st Quarter - Report |
GENENTECH, INC | GENENTECH INC | $3,150,000 | |
| 2024 4th Quarter - Report |
GENENTECH, INC | GENENTECH INC | $1,600,000 | |
| 2024 3rd Quarter - Report |
GENENTECH, INC | GENENTECH INC | $2,470,000 |